stella
beta
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias — Stella
Recruiting
Back to Sickle Cell Anemia trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania
View full record on ClinicalTrials.gov